MedTrace Logo

Radiopharmaceuticals Analysis for Detailed Insights And INternational Tracking of Safety

NCT06483685 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500000

Last updated 2024-07-03

No results posted yet for this study

Summary

Little is known about cancer therapy-related radiopharmaceuticals drugs safety. Here the investigators use VigiBase (http://www.vigiaccess.org/), the World Health Organization (WHO) database of individual safety case reports, to identify and describe cases of cancer therapy-related radiopharmaceuticals drugs.

Conditions

Interventions

DRUG

Radiopharmaceuticals drugs

radiopharmaceuticals drugs included in the Anatomical Therapeutic Chemical (ATC) classification system.

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Jonathan Vigne, PharmD, PhD · CHU de Caen Normandie

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-30
Primary Completion
2024-08-01
Completion
2024-08-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06483685 on ClinicalTrials.gov